GW & Wade’s Amgen AMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $23.1M | Buy |
80,162
+1,400
| +2% | +$381K | 0.75% | 38 |
|
|
2023
Q3 | $21.2M | Buy |
78,762
+1,341
| +2% | +$335K | 0.79% | 35 |
|
|
2023
Q2 | $17.2M | Sell |
77,421
-1,216
| -2% | -$282K | 0.62% | 51 |
|
|
2023
Q1 | $19M | Buy |
78,637
+736
| +0.9% | +$181K | 0.73% | 40 |
|
|
2022
Q4 | $20.5M | Sell |
77,901
-765
| -1% | -$205K | 0.84% | 36 |
|
|
2022
Q3 | $17.7M | Buy |
78,666
+739
| +0.9% | +$179K | 0.87% | 34 |
|
|
2022
Q2 | $19M | Buy |
77,927
+403
| +0.5% | +$98.8K | 0.86% | 35 |
|
|
2022
Q1 | $18.7M | Buy |
77,524
+1,727
| +2% | +$397K | 0.8% | 38 |
|
|
2021
Q4 | $17.1M | Sell |
75,797
-1,797
| -2% | -$379K | 0.74% | 44 |
|
|
2021
Q3 | $16.5M | Buy |
77,594
+1,073
| +1% | +$247K | 0.78% | 41 |
|
|
2021
Q2 | $18.7M | Sell |
76,521
-593
| -0.8% | -$146K | 0.9% | 35 |
|
|
2021
Q1 | $19.2M | Buy |
77,114
+4,710
| +7% | +$1.12M | 1.02% | 30 |
|
|
2020
Q4 | $16.6M | Buy |
72,404
+5,634
| +8% | +$1.3M | 1.01% | 33 |
|
|
2020
Q3 | $17M | Sell |
66,770
-742
| -1% | -$184K | 1.29% | 23 |
|
|
2020
Q2 | $15.9M | Sell |
67,512
-1,360
| -2% | -$310K | 1.3% | 22 |
|
|
2020
Q1 | $14M | Buy |
68,872
+5,815
| +9% | +$1.27M | 1.31% | 21 |
|
|
2019
Q4 | $15.2M | Buy |
63,057
+4,440
| +8% | +$979K | 1.17% | 23 |
|
|
2019
Q3 | $11.3M | Buy |
58,617
+202
| +0.3% | +$38.8K | 0.97% | 33 |
|
|
2019
Q2 | $10.8M | Sell |
58,415
-24,563
| -30% | -$4.4M | 0.98% | 31 |
|
|
2019
Q1 | $15.8M | Buy |
82,978
+23,212
| +39% | +$4.43M | 1.49% | 19 |
|
|
2018
Q4 | $11.6M | Buy |
59,766
+1,108
| +2% | +$216K | 1.26% | 22 |
|
|
2018
Q3 | $12.2M | Buy |
58,658
+4,701
| +9% | +$926K | 1.29% | 24 |
|
|
2018
Q2 | $9.96M | Buy |
53,957
+4,241
| +9% | +$750K | 1.12% | 33 |
|
|
2018
Q1 | $8.48M | Buy |
49,716
+1,401
| +3% | +$257K | 0.98% | 36 |
|
|
2017
Q4 | $8.4M | Buy |
48,315
+59
| +0.1% | +$10.4K | 0.96% | 34 |
|
|
2017
Q3 | $9M | Buy |
48,256
+73
| +0.2% | +$12.9K | 1.09% | 33 |
|
|
2017
Q2 | $8.3M | Buy |
48,183
+820
| +2% | +$133K | 1.05% | 34 |
|
|
2017
Q1 | $7.77M | Buy |
47,363
+17,376
| +58% | +$2.89M | 1.02% | 34 |
|
|
2016
Q4 | $4.38M | Sell |
29,987
-13,764
| -31% | -$2.07M | 0.72% | 37 |
|
|
2016
Q3 | $7.3M | Buy |
43,751
+508
| +1% | +$85.9K | 1.31% | 20 |
|
|
2016
Q2 | $6.58M | Buy |
43,243
+39,009
| +921% | +$6.06M | 1.13% | 22 |
|
|
2016
Q1 | $635K | Buy |
4,234
+53
| +1% | +$7.87K | 0.12% | 102 |
|
|
2015
Q4 | $679K | Buy |
4,181
+1
| +0% | +$157 | 0.14% | 106 |
|
|
2015
Q3 | $578K | Sell |
4,180
-1,708
| -29% | -$269K | 0.13% | 105 |
|
|
2015
Q2 | $904K | Sell |
5,888
-25
| -0.4% | -$4K | 0.18% | 97 |
|
|
2015
Q1 | $945K | Buy |
5,913
+365
| +7% | +$57.5K | 0.18% | 98 |
|
|
2014
Q4 | $884K | Buy |
+5,548
| New | +$864K | 0.23% | 72 |
|
Other funds holding AMGN
GW & Wade's AMGN Position: Q4 2023 in Review
GW & Wade increased its Amgen (AMGN) stake by 1.8% in Q4 2023, buying an estimated $381K and bringing the position to 80,162 shares worth $23.1M. The position accounts for 0.75% of the portfolio, ranked #38.
GW & Wade first reported a position in AMGN in Q4 2014 and has held it in 37 quarters since. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q4 2023.
- GW & Wade held 80,162 shares of Amgen worth $23.1M as of Q4 2023.
- GW & Wade bought 1,400 Amgen shares in Q4 2023, an estimated $381K.
- Amgen made up 0.75% of GW & Wade's portfolio in Q4 2023, its #38 holding.
- GW & Wade first reported a position in Amgen in Q4 2014 and has held it in 37 quarters since.
- 2,715 funds tracked by Wall St. Rank held Amgen as of Q4 2023.
Based on GW & Wade's 13F filing for Q4 2023, filed 8 Feb 2024.